PGY2 Oncology Pharmacy Residency

National Match Code: 635260

PGY2 Oncology Program Director
Emma Carroll, PharmD, BCOP
Telephone: 414-805-3145
E-mail: [email protected]

PGY2 Oncology Program Coordinator
Sara Bugamelli, PharmD, BCOP
E-mail: [email protected]

Duration/Type: 12-month residency
Number of Positions: 4
Application Deadline: Jan. 2, 2025
Starting Date: July 7, 2025
Stipend: $53,040

PGY2 Oncology Preceptors

The purpose of this PGY2 pharmacy residency program is to build on Doctor of Pharmacy (PharmD) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification.

Features

This specialty residency is designed to provide advanced clinical training in oncology and leadership development opportunities. Upon completion of the residency, the graduates’ advanced knowledge and leadership skills will enable them to practice as an integral member of an interdisciplinary team in the care of the oncology patient, engage in clinical instructor/precepting opportunities and they will be prepared to attain board certification (BCOP).

Flexible, comprehensive training in both acute care and ambulatory oncology settings with a focus on multidisciplinary collaboration.

• Rotations and activities are tailored to meet the needs and interests of each resident.
• Year-long research projects will be ready to be submitted for publication.
• Residents will have the opportunity to precept PGY1 pharmacy residents and PharmD students on clinical rotations.

Requirements for Acceptance

• Completion of PGY1 pharmacy residency
• Applicants are required to submit a program application through PhORCAS. Please follow the application instructions.

Learning Experiences

Required Rotations

• Orientation and Training
  • Orientation (1 week)
  • Inpatient Training (1 – 3 weeks)
  • Infusion Training (3 weeks)
  • Clinic Training (1 week) 
• Inpatient Rotations
  • Inpatient Oncology (Solids) (2 – 3 weeks)
  • Inpatient Hematologic Malignancies (4 weeks)
  • Inpatient Blood and Marrow Transplant (4 weeks)
• Ambulatory Care
  • Hematology/Blood and Marrow transplant (Grace Clinic – 4 weeks)
  • Gastrointestinal Malignancies (Faith Clinic – 2 weeks)
  • Gynecology and Thoracic Malignancies (Courage Clinic – 2 weeks)
  • Breast Cancer (Breast Care Clinic – 2 weeks)
  • Genitourinary and Sarcoma Malignancies (Life Clinic – 2 weeks)
• Head & Neck, Central Nervous System, Skin, and Endocrine Malignancies (Hope Clinic – 2 weeks)
• Investigational Drug Service (3 weeks)
• Longitudinal Experiences
  • Drug Policy (Collaboration with Oncology Pharmacy & Therapeutics Subcommittee – 3 months)
  • Multidisciplinary Collaboration (Collaboration with Oncology Pharmacy & Nursing Committee – 3 months)
  • Pharmacogenomics (Collaboration with Molecular Tumor Board – 3 months)
  • Medication Safety and Leadership (Medication Error Review and Reporting – 3 months)
  • Clinical and Operations Practice (Staffing) (52 weeks, every 3rd weekend (Sa, Su, 8-hour shifts and 5 weeks (M-F, 8 hour shifts)
  • Longitudinal Research Project (52 weeks)
  • Weekly Oncology Residency Discussion (WORDs) (52 weeks)

Elective Rotations

• Academia Advanced (2 – 4 weeks)
• Infectious Disease (2 – 4 weeks)
• Pharmacy Informatics (3 – 4 weeks)
• Critical Care Oncology (2 – 4 weeks)
• Advanced Practice Oncology (2 – 4 weeks)
• Pediatric Oncology (Children’s Hospital of Wisconsin – 3 – 4 weeks)
• Precision Medicine (2 weeks)
• Specialty Pharmacy – Oncology (2 – 4 weeks)

Opportunities for elective experiences that could be developed based on interest include: oncology pain stewardship, oncology palliative care, oncology medical writing, oncology leadership

Requirements and Expectations

In addition to requirements for individual learning experiences and program requirements outlined previously in the manual, satisfactory completion of the below list is required to earn a Froedtert Hospital PGY-2 Oncology Residency certificate. The Graduation Requirement Checklist for PGY2 Oncology Residency Program will be completed and signed off by the end of the residency year and uploaded to PharmAcademic.

Clinical and Operations Practice (On-Site Staffing) Requirements 

Includes weekend shifts, weekday shifts (Mon-Fri), holiday shifts, and up to four additional weekday shifts.

• Staffing is prioritized to be staffed in oncology areas; however, residents may be assigned or volunteer for non-oncology shifts as available in cross-trained areas
• Weekends will be rotated among the four PGY2 oncology residents in an every 3rd week pattern, with exceptions for training and end of year.
• The weekend consists of two 8 hour shifts (Saturday and Sunday).
• 5 weeks of weekday staffing is assigned Monday through Friday, 8 hour shifts, assigned as needed
• Two – 8 hour holiday shifts (1 minor, 1 major)
• Up to 4 ad-hoc shifts to accommodate department needs
• Resident staffing beyond the above requirements are eligible for bonus pay (see section on bonus shifts)
• Residents will be given 4 comp days for weekend staffing (1 per quarter) scheduled in advance. Preceptors, RPD, and oncology manager should be notified in advance of comp day.

Investigational Drug Service (IDS) Call for PGY2 Oncology Residents

Training:

• Training session during orientation
• First two on-call weekends will be used for training with the back-up IDS pharmacist
• Residents will have a back-up pharmacist for all on-call weekends 

Schedule Expectations:

• Residents are expected to take call usually on assigned staffing weekend and holiday staffing assignment shifts (holiday coverage is minor/major holiday for the day and overnight; ~ 11 weekends). 
• Residents are responsible to cover the IDS pager from 1630 on Friday through 0700 on Monday

ASHP Required Objectives and PharmAcademic Learning Experience Evaluations

• All PharmAcademic evaluations and cosignatures will be completed and submitted within 7 days of due date.
• 70% objectives ACHR (Achieved for residency) and all remaining objectives satisfactory progress (SP) • 100% Patient Care objectives (R1) ACHR
• Completion of Appendix Checklist

ASHP Required Competency Areas, Goals, and Objectives (CAGO) Deliverables

These items are required to be completed by the end of the year and uploaded to Pharmacademic.

• Three individual redacted Epic notes
• Drug class review, monograph, treatment guideline, policy, or protocol related to care of oncology patients (not including MUE or IDS documents).
• MUE or document completed on drug policy rotation
• Final presentation given to OPNC on medication safety rotation
• HOPA manuscript and poster presentation
• Any additional projects that contributed to the oncology department
• Two CE presentations
• CE assessments for both CEs presented
• Example of written communication (such as newsletters, written drug information, presentations)
• Final pharmacy summary and oral drug monograph created on IDS rotation

Quarterly Development Planning

Quarterly Development Planning Meetings

• Attendance – RPD, RPC, resident, mentor, project advisor (optional- may provide feedback to RPD/RPC and resident in advance)
• Goals – Update development plan with progress towards graduation requirements, assessment of progress on previously identified opportunities for improvement related to the competency areas, identification of new strengths and opportunities for improvement related to competency areas, change in practice interests, career goals, and an assessment of well-being and resilience.
• Plan – RPD to schedule 1 hour meetings. Initial Development plan will occur within 30 days from residency start date. Q1, 2 and 3 meetings will occur approximately every 90 days from the start of the residency year.
• Mentors

Resident Research Project

Residents will choose a longitudinal research project at the beginning of the year and will form a project team. Residents are required to complete the following throughout the year:

• CITI / GCP Training
• Pharmacy Research Committee Protocol Approval
• IRB submission (if applicable)
• Each resident is required to attend and present at one clinical conference in the year (poster and abstract). The preference is HOPA annual conference but may be an alternative meeting as reviewed with residency leadership.
• Summative Presentation for Froedtert Staff
• Manuscript
• Resident research project must be summarized in a written format acceptable for publication. Residents are encouraged to pursue publication and/or presentation of their project in a peer-review setting.

Continuing Education (CE)

• Each resident will develop and present two formal CEs throughout the year.
• A preceptor will be selected as a mentor for each CE prior to finalizing topic.
• Gap Analysis & Activity Planning is due 6 weeks prior to presentation
• Disclosure form due 6 weeks in advance
• Final slides due 3 weeks prior to presentation
• Audience feedback will be provided to the resident after each presentation

Academia

• PGY2 Oncology Residents are required to participate in two oncology-focused student labs with MCW School of Pharmacy

PGY2 Oncology Residency Additional Opportunities and Information

Academic Half-Day

• You will be given a half-day every Wednesday (12pm – 4:30pm) to work on project, schedule meetings, attend academic afternoon discussions, WORDs, etc. This is subject to change, if needed.
• It is preferred that meetings be scheduled during this time as not to take away from rotation time.

Department Meeting Attendance

Residents are expected to be present at the meetings below that occur during learning experience time. It is acceptable to miss a meeting for patient care needs; however, the situation should be communicated to the RPD or RPC. During staffing, meeting attendance is not required and the resident is exempt unless workload permits and the resident confirms with their staffing colleagues. The resident should not schedule additional meetings during staffing shifts (ie. mentor meetings, project team meetings, etc).

• Weekly Oncology Residency Discussions (WORDs)
• Oncology Continuing Education

Mentorship Experiences

Residency mentors are pharmacists assigned to each resident. Their primary purpose is to provide residents guidance throughout the year with an emphasis on self-assessment growth, review and provide feedback on major projects, monitor progress with residency expectations, and facilitate communication between rotations

• Provide guidance throughout the year on overall professional development and career planning.
• Residents and mentors are expected to meet approximately monthly

Program Feedback Expectations

• Residents are an integral component to the continuing development and improvement of the residency program
• Meet with RPD/RPC to provide formal feedback throughout year – Orientation/Training – Midpoint – Final

Recruitment

• PGY2 Residents have an active role in recruitment for incoming PGY2 Oncology pharmacy residency class
• Responsibilities vary based on availability and scheduling, may include: 
  • ASHP Personnel Placement Service Interviews
  • Networking events with candidates (i.e. ASHP residency showcase)
  • Developing interview schedules, questions, logistics
  • Coordinating, transitioning, directing on interview days
  • Candidate lunch and tours for interview days

Student and PGY1 Resident Precepting Opportunities

• May serve as primary preceptor for IPPE students, based on scheduled learning experiences
• Assist with precepting responsibilities for APPE students during learning experiences, including longitudinal 
• Assist with precepting PGY-1 residents completing oncology based learning experiences
• Preceptor development series discussions
• Borrow and read ASHP’s “The Effective Pharmacy Preceptor”

Committee Opportunities and Responsibility

Optional Opportunities

• Vizient Pharmacy Cancer Care Committee
• Froedtert Institutional Review Board Meeting- coordinate with IDS learning experience

Professional Organization Membership

Professional organizations offer residents additional resources and education opportunities as well as access to networking outside of Froedtert & the Medical College of Wisconsin health network. Residents are highly encouraged to engage in active membership in at least one professional organization during residency and to continue to build upon membership into their careers.

• Hematology & Oncology Pharmacy Association (HOPA)
• American Society of Blood & Marrow Transplant (ASBMT) Pharmacy SIG
• American Society of Health-System Pharmacists (ASHP)
• Pharmacy Society of Wisconsin (PSW)
• American College of Clinical Pharmacy (ACCP)
• National Comprehensive Cancer Network (NCCN)

Professional Conference Attendance

• Vizient Clinical Meeting (required if attending ASHP Midyear Clinical Meeting)
• ASHP Midyear Clinical Meeting
• Milwaukee Residency Conferences
• BMT Tandem Annual meeting
• Pharmacy Society of Wisconsin (PSW) Annual Meeting or Educational Conference
• HOPA Practice Management Meeting
• Local/Regional Oncology Pharmacy Conferences

Formal Presentations (optional)

• HOPA National Journal Club Presentation
• American Society for Transplantation and Cellular Therapy (ASTCT) Pharmacy SIG Education Committee Journal Club
• Oncology care support group meeting
• Froedtert/Advocate Aurora Potluck Journal Club

Past Residents